<?xml version="1.0" encoding="UTF-8"?>
<ref id="B39">
 <label>39.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Fournillier</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Frelin</surname>
    <given-names>L</given-names>
   </name>
   <name>
    <surname>Jacquier</surname>
    <given-names>E</given-names>
   </name>
   <name>
    <surname>Ahlen</surname>
    <given-names>G</given-names>
   </name>
   <name>
    <surname>Brass</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Gerossier</surname>
    <given-names>E</given-names>
   </name>
   <etal/>
  </person-group>. 
  <article-title>A heterologous prime/boost vaccination strategy enhances the immunogenicity of therapeutic vaccines for hepatitis C virus</article-title>. 
  <source>J Infect Dis.</source> (
  <year>2013</year>) 
  <volume>208</volume>:
  <fpage>1008</fpage>â€“
  <lpage>19</lpage>. 
  <pub-id pub-id-type="doi">10.1093/infdis/jit267</pub-id>
  <?supplied-pmid 23776192?>
  <pub-id pub-id-type="pmid">23776192</pub-id>
 </mixed-citation>
</ref>
